Cover Image
市場調查報告書

美國的輸血診斷市場

The US Blood Transfusion Diagnostics Market

出版商 Frost & Sullivan 商品編碼 325793
出版日期 內容資訊 英文 113 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
美國的輸血診斷市場 The US Blood Transfusion Diagnostics Market
出版日期: 2015年03月10日 內容資訊: 英文 113 Pages
簡介

本報告提供以血液捐贈者樣品實施的診斷檢驗的相關調查,各種類分析、捐贈者血清檢驗、血型判斷,及分子檢驗的檢驗數與價格分析、市場預測、供應商的市場佔有率、產品分析,及新市場機會等彙整資料,為您概述為以下內容。

第1章 摘要整理

第2章 市場概要

  • 市場背景
  • 市場背景:血庫分析儀的種類
  • 免疫血液學手法比較
  • 客戶的迴響:影響輸血實驗室的設備購買的要素
  • 客戶的迴響
  • 市場區隔
  • 採購流程
  • 未來的醫療趨勢定義

第3章 競爭劇本

  • 新的市場機會

第4章 促進要素、阻礙要素、趨勢:總輸血診斷市場

  • 促進要素
  • 阻礙要素
  • 趨勢的市場影響前6名

第5章 預測、趨勢:總輸血診斷市場

  • 檢測
  • 市場預測的影響要素
  • 收益預測
  • 收益預測的議論

第6章 血型判斷區分分析

  • 收益預測
  • 收益預測的議論
  • ABO、Rh、RBC抗原型、抗體特定,及篩檢的檢驗數
  • ABO、Rh,及RBC抗原型的醫療費
  • 血型判斷檢驗的檢驗數、價格分析
  • 抗體篩檢、鑑定,及交叉選配的醫療保險費用

第7章 疾病篩檢區分分析

  • 收益預測
  • 血清、分子的收益預測
  • 收益預測的議論
  • 疾病篩檢、NAT實驗的實驗數、價格分析
  • 血清捐贈者檢驗的檢驗數
  • 血清、NAT檢驗,每1件的成本比較
  • 最頻繁訂購的血液檢驗:各排名

第8章 公認輸血中心

  • 公認的免疫血液學相關實驗室
  • 輸血中心

第9章 血庫供應鏈概要

  • 血庫的供應鏈概要
  • 問題的領域、解決方案

第10章 競爭環境

  • 市場佔有率
  • 市場佔有率分析
  • 產品分析:血型判斷
  • 產品分析:疾病篩檢 (血清、分子)
  • 產品分析:疾病篩檢 (分子化驗)
  • 吸收、合併,及聯盟的評估

第11章 企業簡介

  • Immucor
  • Ortho Clinical Diagnostics
  • Beckman Coulter (Danaher)
  • BioRad

第12章 主要關注企業

  • Quotient Limited (previously known as Alba Bioscience)
  • Immucor
  • Diagast
  • 3Ti (Transfusion & Transplantation Technologies)

第13章 結論

第14章 附錄

目錄
Product Code: NE4E-01-00-00-00

Effective Strategies for Vendors to Tackle the Decrease in Blood Supply Demand

This research study focuses on diagnostic tests performed on blood donor samples. The market segments are divided by blood grouping and disease screening and cover manual and automated instruments as well as reagents used for Abo and Rh testing, RBC antigen, and antibody identification and detection. Disease screening includes both serological and molecular testing. Comprehensive reports on test volume and pricing analysis for donor serological tests, blood grouping, and molecular tests are provided. The market forecasts begin in 2015 and end in 2018 using a base year of 2014. Supplier market shares, extensive product analysis, and new market opportunities to tackle the decreasing demand for blood supply are discussed.

Key Questions This Study Will Answer

  • How is innovation changing the donor disease screening and blood grouping landscape?
  • Are the products/services offered today meeting customer needs or is additional development needed?
  • Will these products/services continue to exist, or will other companies acquire them?
  • Are the vendors in the space ready to go it alone, or do they need partnerships to take their businesses to the next level?
  • What was the trend in price for blood grouping and typing in 2012 and 2013? Has it increased or decreased?
  • What was the trends in price for disease screening tests in 2012 and 2013? Has it increased or decreased?

Table of Contents

1. EXECUTIVE SUMMARY

Executive Summary

  • 1. Key Findings
  • 2. Key Findings (continued)
  • 3. Scope and Segmentation
  • 4. Market Segmentation
  • 5. Key Questions This Study Will Answer
  • 6. Measurements
  • 7. CEO's Perspective
  • 8. Key Companies to Watch
  • 9. Key Companies to Watch (continued)
  • 10. Executive Summary-2 Big Predictions
  • 11. Executive Summary-2 Big Predictions (continued)
  • 12. Executive Summary-2 Big Predictions (continued)

2. MARKET OVERVIEW

Market Overview

  • 1. Market Background
  • 2. Market Background-Types of Blood Bank Analyzers
  • 3. Market Background-Types of Blood Bank Analyzers (continued)
  • 4. Market Background-Types of Blood Bank Analyzers (continued)
  • 5. Comparison of Immunohematology Methods
  • 6. Voice of Customer-Factors Governing Equipment Purchase for a Transfusion Laboratory
  • 7. Voice of Customer
  • 8. Market Segmentation
  • 9. Procurement Process
  • 10. Defining Future Healthcare Trends

3. COMPETITIVE PLAYBOOK

Competitive Playbook

  • 1. New Market Opportunities
  • 2. New Market Opportunities (continued)

4. DRIVERS, RESTRAINTS, AND TRENDS-TOTAL BLOOD TRANSFUSION DIAGNOSTICS MARKET

Drivers, Restraints, and Trends-Total Blood Transfusion Diagnostics Market

  • 1. Market Drivers
  • 2. Market Restraints
  • 3. Market Impact of Top 6 Trends

5. FORECASTS AND TRENDS-TOTAL BLOOD TRANSFUSION DIAGNOSTICS MARKET

Forecasts and Trends-Total Blood Transfusion Diagnostics Market

  • 1. Measurements
  • 2. Measurements (continued)
  • 3. Factors Impacting Market Forecasts
  • 4. Revenue Forecast
  • 5. Revenue Forecast Discussion

6. BLOOD GROUPING SEGMENT ANALYSIS

Blood Grouping Segment Analysis

  • 1. Revenue Forecast
  • 2. Revenue Forecast Discussion
  • 3. Revenue Forecast Discussion (continued)
  • 4. Test Volume for Abo, Rh, RBC Antigen Typing, Antibody Identification, and Screening
  • 5. Medicare Expenditure for Abo, Rh, and RBC Antigen Typing
  • 6. Test Volume and Pricing Analysis for Blood Grouping Tests
  • 7. Test Volume and Pricing Analysis for Blood Grouping Tests (continued)
  • 8. Medicare Expenditure for Antibody Screening, Identification, and Cross Matching

7. DISEASE SCREENING SEGMENT ANALYSIS

Disease Screening Segment Analysis

  • 1. Revenue Forecast
  • 2. Revenue Forecast for Serological and Molecular
  • 3. Revenue Forecast Discussion
  • 4. Revenue Forecast Discussion (continued)
  • 5. Test Volume and Pricing Analysis for Disease Screening and NAT Tests
  • 6. Test Volume Serological Donor Screening Tests
  • 7. Test Volume Serological Donor Screening Tests (continued)
  • 8. Cost Comparison per Test for Serological and NAT
  • 9. Most Frequently Ordered Blood Tests by Rank

8. ACCREDITED TRANSFUSION CENTERS

Accredited Transfusion Centers

  • 1. Accredited Immunohematology Reference Laboratories
  • 2. Accredited Immunohematology Reference Laboratories (continued)
  • 3. Accredited Immunohematology Reference Laboratories (continued)
  • 4. Accredited Immunohematology Reference Laboratories (continued)
  • 5. Accredited Immunohematology Reference Laboratories (continued)
  • 6. Blood Transfusion Centers

9. OVERVIEW OF BLOOD BANK SUPPLY CHAIN

Overview of Blood Bank Supply Chain

  • 1. Overview of Supply Chain in Blood Banks
  • 2. Overview of Supply Chain in Blood Banks (continued)
  • 3. Problem Areas and Solution

10. COMPETITIVE ENVIRONMENT

Competitive Environment

  • 1. Market Share
  • 2. Market Share Analysis
  • 3. Product Analysis Blood Grouping
  • 4. Product Analysis Blood Grouping (continued)
  • 5. Product Analysis Disease Screening (Serological and Molecular)
  • 6. Product Analysis Disease Screening (Molecular Assays)
  • 7. Merger, Acquisition, and Partnership Assessment
  • 8. Merger, Acquisition, and Partnership Assessment (continued)
  • 9. Merger, Acquisition, and Partnership Assessment (continued)
  • 10. Merger, Acquisition, and Partnership Assessment (continued)

11. COMPANY PROFILES

Company Profiles

  • 1. Immucor
  • 2. Ortho Clinical Diagnostics
  • 3. Beckman Coulter (Danaher)
  • 4. BioRad

12. KEY COMPANIES TO WATCH

Key Companies to Watch

  • 1. Quotient Limited (previously known as Alba Bioscience)
  • 2. Immucor
  • 3. Diagast
  • 4. 3Ti (Transfusion & Transplantation Technologies)

13. THE LAST WORD

The Last Word

  • 1. The Last Word-2 Big Predictions
  • 2. The Last Word-Discussion
  • 3. The Last Word-Discussion (continued)
  • 4. Legal Disclaimer

14. APPENDIX

Appendix

  • 1. Drivers Explained
  • 2. Drivers Explained (continued)
  • 3. Restraints Explained
  • 4. Restraints Explained (continued)
  • 5. Restraints Explained (continued)
  • 6. Restraints Explained (continued)
  • 7. Restraints Explained (continued)
  • 8. Additional Studies of Interest
  • 9. Additional Studies of Interest (continued)
  • 10. Methodology
  • 11. Learn More-Next Steps
  • 12. List of Exhibits
  • 13. List of Exhibits (continued)
  • 14. List of Exhibits (continued)
  • 15. List of Exhibits (continued)
Back to Top